FilingReader Intelligence
Yifan Pharma profit jumps 20% despite flat revenues
August 14, 2025 at 05:44 PM UTC•By FilingReader AI
Yifan Pharmaceutical reported net profit attributable to shareholders up 19.91% to 303.7 million yuan for the first half of 2025, despite revenues rising just 0.11% to 2.64 billion yuan.
The company is bolstering its biological and chemical pharmaceutical sectors while emphasizing innovation and global market expansion.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
amendment to the articles of associationAugust 14, 2025 at 08:00 AM UTC
2025 semi-annual reportAugust 14, 2025 at 08:00 AM UTC
Notice on convening the second extraordinary general meeting of shareholders in 2025August 14, 2025 at 08:00 AM UTC
Announcement regarding the election for the re-election of the board of directorsAugust 14, 2025 at 08:00 AM UTC
Summary of the 2025 semi-annual reportAugust 14, 2025 at 08:00 AM UTC
Announcement of the supervisory board resolution regarding the semi-annual reportAugust 14, 2025 at 08:00 AM UTC
Announcement of board of directors' resolutions regarding the semi-annual reportAugust 14, 2025 at 08:00 AM UTC
SZSE:002019•Shenzhen Stock Exchange
News Alerts
Get instant email alerts when Yifan Pharmaceutical publishes news
Free account required • Unsubscribe anytime